← Back to Search

Behavioural Intervention

Voice Assistant Device for Medication Adherence (MIVA Trial)

N/A
Waitlist Available
Led By Kevin Schulman, MD, MBA
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients with Type 2 Diabetes with most recent A1c at least 8% within the past year
Patients clinically indicated to be taking daily long-acting insulin
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 3 and 8 weeks (assessed at the end of each 3 day period)
Awards & highlights

MIVA Trial Summary

This trial is testing whether an AI-enabled smart speaker device can help manage insulin titration, increase insulin adherence, and improve glycemic control.

MIVA Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

MIVA Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 3 and 8 weeks (assessed at the end of each 3 day period)
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 3 and 8 weeks (assessed at the end of each 3 day period) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Attitudes Toward Diabetes
Attitudes Toward Health Technology
Attitudes Toward Medication Adherence
+2 more
Secondary outcome measures
Glycemic Improvement
Percentage of Participants Who Achieved Glycemic Control

MIVA Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Voice Assistant DeviceExperimental Treatment1 Intervention
Subjects have their insulin titrated by a voice assistant device for 8 weeks. The Voice Assistant Device software algorithm is used to provide daily insulin dose and titration instructions.
Group II: ControlActive Control1 Intervention
Subjects have their insulin titrated via standard of care for 8 weeks. The Voice Assistant Device is limited to providing a daily reminder to take medication.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Voice Assistant Device
2021
N/A
~40

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,373 Previous Clinical Trials
17,327,923 Total Patients Enrolled
Kevin Schulman, MD, MBAPrincipal InvestigatorStanford University
Ashwin Nayak, MDPrincipal InvestigatorStanford University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To what extent has enrollment for this research project been maximized?

"Affirmative. Data found on the clinicaltrials.gov website shows that this medical trial is currently recruiting, having first being posted on March 24th 2021 and last updated on June 9th 2022. The study is hoping to enroll 50 candidates at a single location."

Answered by AI

Are there still opportunities for enrolment in this experiment?

"The clinicaltrials.gov website confirms that this study is still in the process of recruiting participants, with the trial being first posted on March 24th 2021 and last updated on June 9th 2022."

Answered by AI
~10 spots leftby Mar 2025